UNITED PHARMA TECHNOLOGIES H-1B Visa Sponsorship & Salary Data

The median H-1B salary at UNITED PHARMA TECHNOLOGIES is $93,600, based on 249 certified filings from FY 2020 to FY 2026. This is 22% lower than the national H-1B median salary of $120,000. Compensation at UNITED PHARMA TECHNOLOGIES reflects their market positioning, with entry-level roles starting around $87,422 and senior positions reaching $123,656 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at UNITED PHARMA TECHNOLOGIES range from $79,539 at the 10th percentile to $123,656 at the 90th percentile, showing a $44,117 spread across experience levels and roles. The 25th percentile is $87,422 and the 75th percentile is $112,736.

Yes, UNITED PHARMA TECHNOLOGIES actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), UNITED PHARMA TECHNOLOGIES filed 37 H-1B labor condition applications with 35 certified and 0 denied, at a median salary of $104,000. Across FY 2020–2026, they have filed 262 total H-1B applications with 249 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. UNITED PHARMA TECHNOLOGIES sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), UNITED PHARMA TECHNOLOGIES filed 37 H-1B applications, with 35 certified and 0 denied. Over 7 years of data, UNITED PHARMA TECHNOLOGIES has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

UNITED PHARMA TECHNOLOGIES's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 262 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating UNITED PHARMA TECHNOLOGIES as a potential H-1B sponsor.

This is an excellent approval rate, indicating UNITED PHARMA TECHNOLOGIES has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

UNITED PHARMA TECHNOLOGIES sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 249 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles UNITED PHARMA TECHNOLOGIES most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at UNITED PHARMA TECHNOLOGIES:

The most frequently sponsored role is Validation Engineer with 111 filings at a median salary of $92,165. This is followed by Csv Engineer (8 filings) and Quality Validation Engineer.

UNITED PHARMA TECHNOLOGIES's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where UNITED PHARMA TECHNOLOGIES sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top UNITED PHARMA TECHNOLOGIES H-1B locations:

The largest H-1B hub for UNITED PHARMA TECHNOLOGIES is South Plainfield, NJ with 26 filings at a median salary of $89,398. The highest-paying location is Rahway, NJ at $120,640 median. Salaries range from $83,200 to $120,640 across office locations.

UNITED PHARMA TECHNOLOGIES's median H-1B salary has increased by +21% from FY 2020 ($85,717) to FY 2026 ($104,000). Tracking salary trends over time reveals how UNITED PHARMA TECHNOLOGIES adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at UNITED PHARMA TECHNOLOGIES.

Year-by-year breakdown:

• FY 2022: $101,899 (2 certified)
• FY 2023: $104,125 (60 certified)
• FY 2024: $91,520 (63 certified)
• FY 2025: $99,840 (44 certified)
• FY 2026: $104,000 (35 certified)

This 21% growth reflects strong compensation adjustments at UNITED PHARMA TECHNOLOGIES, keeping pace with market demands for H-1B talent.

UNITED PHARMA TECHNOLOGIES primarily files H-1B applications at Wage Level II, accounting for 71% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making UNITED PHARMA TECHNOLOGIES's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 99% of positions at Level II or higher, UNITED PHARMA TECHNOLOGIES typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

UNITED PHARMA TECHNOLOGIES's median H-1B salary of $93,600 is 22% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating UNITED PHARMA TECHNOLOGIES's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare UNITED PHARMA TECHNOLOGIES's offerings with similar companies in your field for a more accurate assessment.

UNITED PHARMA TECHNOLOGIES's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. UNITED PHARMA TECHNOLOGIES files 1% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 249 certified filings, UNITED PHARMA TECHNOLOGIES invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.